Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
MASH Rec CARD (13)
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: September 11, 2023

  1. Home>
  2. 2023>
  3. September>
  4. 11
NXP800 for Cholangiocarcinoma Earns Orphan Drug Designation
Source: pixabay.com

NXP800 for Cholangiocarcinoma Earns Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:September 11, 2023
  • Post category:Bile duct cancer/Biliary tract cancer/Cholangiocarcinoma

  In the United States, the FDA grants Orphan Drug designation to drugs or biologics that are intended to treat, diagnose, or prevent rare conditions. A rare condition is one…

Continue Reading NXP800 for Cholangiocarcinoma Earns Orphan Drug Designation
The Benefits of Treating Pediatric Retinoblastoma with Intra-Arterial Chemotherapy
source: pixabay.com

The Benefits of Treating Pediatric Retinoblastoma with Intra-Arterial Chemotherapy

  • Post author:Jessica Lynn
  • Post published:September 11, 2023
  • Post category:Retinoblastoma

Retinoblastoma is a rare cancer that begins in the retina, or the sensitive lining in the back of your eye. While it can affect people of all ages, it is…

Continue Reading The Benefits of Treating Pediatric Retinoblastoma with Intra-Arterial Chemotherapy
ICYMI: Mitazalimab Was Granted EMA Orphan Drug Status for Pancreatic Cancer
mohamed_hassan / Pixabay

ICYMI: Mitazalimab Was Granted EMA Orphan Drug Status for Pancreatic Cancer

  • Post author:Jessica Lynn
  • Post published:September 11, 2023
  • Post category:Pancreatic Cancer

245 words (source - 6% match) vs. 386 words (mine - 4% match)  In the European Union, Orphan designation is granted to therapies intended to treat or use for a…

Continue Reading ICYMI: Mitazalimab Was Granted EMA Orphan Drug Status for Pancreatic Cancer
Topline Results are Available from a Study Evaluating AMO-O2 for Congenital DM1
source: pixabay.com

Topline Results are Available from a Study Evaluating AMO-O2 for Congenital DM1

  • Post author:Jessica Lynn
  • Post published:September 11, 2023
  • Post category:Myotonic Dystrophy

  The 2023 Annual Meeting of the Myotonic Dystrophy Foundation took place from September 7-9 this year. During the meeting, stakeholders gathered in the nation's capital to discuss research, trends,…

Continue Reading Topline Results are Available from a Study Evaluating AMO-O2 for Congenital DM1
You Are Not Alone: Empowering the Advanced Kidney Cancer Community
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
Read Full Story Here
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info